Centre SLA, CHRU de Tours, Tours, France; UMR INSERM U930, Université François Rabelais de Tours, Tours, France.
J Neurol Sci. 2011 Oct 15;309(1-2):16-7. doi: 10.1016/j.jns.2011.07.044. Epub 2011 Aug 17.
The optineurin (OPTN) gene, known to be implicated in primary open-angle glaucoma (POAG), is the more recent genetic factor linked to ALS. We report the case of a 75year-old man who developed ALS and whose medical history was dominated by a familial POAG. The absence of OPTN gene mutation in a patient who suffered from two conditions linked to mutations of this gene does not support involvement of OPTN in ALS.
已知视神经萎缩症(OPTN)基因与原发性开角型青光眼(POAG)有关,是最近与肌萎缩侧索硬化症(ALS)相关的遗传因素。我们报告了一例 75 岁男性患者,他患有 ALS,其病史以家族性 POAG 为主。在患有两种与该基因突变相关的疾病的患者中未发现 OPTN 基因突变,这并不支持 OPTN 参与 ALS 的发病。